PPA
CO

Parametric Portfolio Associates’s Global Cord Blood Corporation CO Stock Holding History

Parametric Portfolio Associates’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$376K Buy
97,700
+64,391
+193% +$267K ﹤0.01% 3208
2021
Q4 		$140K Sell
33,309
-1,373
-4% -$5.83K ﹤0.01% 3499
2021
Q3 		$162K Sell
34,682
-15,010
-30% -$73.6K ﹤0.01% 3475
2021
Q2 		$265K Sell
49,692
-12,225
-20% -$64K ﹤0.01% 3304
2021
Q1 		$280K Sell
61,917
-26,443
-30% -$115K ﹤0.01% 3747
2020
Q4 		$328K Buy
88,360
+2,364
+3% +$9.07K ﹤0.01% 3558
2020
Q3 		$304K Buy
85,996
+8,252
+11% +$28.6K ﹤0.01% 3482
2020
Q2 		$241K Sell
77,744
-335
-0.4% -$973 ﹤0.01% 3562
2020
Q1 		$248K Sell
78,079
-3,686
-5% -$16.1K ﹤0.01% 3461
2019
Q4 		$409K Sell
81,765
-5,051
-6% -$24.1K ﹤0.01% 3441
2019
Q3 		$420K Sell
86,816
-7,653
-8% -$40.1K ﹤0.01% 3405
2019
Q2 		$546K Buy
94,469
+15,934
+20% +$105K ﹤0.01% 3327
2019
Q1 		$551K Buy
78,535
+4,274
+6% +$28.2K ﹤0.01% 3285
2018
Q4 		$479K Sell
74,261
-10,668
-13% -$68.2K ﹤0.01% 3333
2018
Q3 		$594K Buy
84,929
+32,033
+61% +$241K ﹤0.01% 3348
2018
Q2 		$502K Sell
52,896
-256
-0.5% -$2.45K ﹤0.01% 3346
2018
Q1 		$542K Buy
53,152
+5,054
+11% +$51.6K ﹤0.01% 3309
2017
Q4 		$479K Buy
48,098
+16,664
+53% +$182K ﹤0.01% 3347
2017
Q3 		$350K Sell
31,434
-3,108
-9% -$36.4K ﹤0.01% 3608
2017
Q2 		$327K Buy
34,542
+15,620
+83% +$125K ﹤0.01% 3594
2017
Q1 		$126K Sell
18,922
-1,008
-5% -$5.97K ﹤0.01% 3676
2016
Q4 		$122K Buy
19,930
+2,366
+13% +$11.8K ﹤0.01% 3679
2016
Q3 		$90K Buy
17,564
+1,674
+11% +$8.93K ﹤0.01% 3694
2016
Q2 		$91K Sell
15,890
-294
-2% -$1.79K ﹤0.01% 3734
2016
Q1 		$98K Buy
16,184
+339
+2% +$2.02K ﹤0.01% 3867
2015
Q4 		$101K Buy
15,845
+4,036
+34% +$25.5K ﹤0.01% 3856
2015
Q3 		$71K Buy
11,809
+766
+7% +$4.76K ﹤0.01% 3220
2015
Q2 		$68K Sell
11,043
-1,715
-13% -$10.5K ﹤0.01% 3910
2015
Q1 		$65K Buy
12,758
+59
+0.5% +$290 ﹤0.01% 3899
2014
Q4 		$57K Buy
+12,699
New +$60.3K ﹤0.01% 3939

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Parametric Portfolio Associates's CO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Global Cord Blood Corporation (CO) stake by 193% in Q1 2022, buying an estimated $267K and bringing the position to 97,700 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #3208.

Parametric Portfolio Associates first reported a position in CO in Q4 2014 and has held it in 30 quarters since. The position peaked at $594K in Q3 2018. 29 funds tracked by Wall St. Rank hold CO as of Q1 2022.

  • Parametric Portfolio Associates held 97,700 shares of Global Cord Blood Corporation worth $376K as of Q1 2022.
  • Parametric Portfolio Associates bought 64,391 Global Cord Blood Corporation shares in Q1 2022, an estimated $267K.
  • Global Cord Blood Corporation made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3208 holding.
  • Parametric Portfolio Associates first reported a position in Global Cord Blood Corporation in Q4 2014 and has held it in 30 quarters since.
  • Parametric Portfolio Associates's Global Cord Blood Corporation position peaked at $594K in Q3 2018.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.